Matthew Winton - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 4, 2026
Matthew Winton is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $117K.
Profile
Matthew Winton is the Chief Commercial and Business at CervoMed Inc. (CRVO). SEC records also connect Winton to Inozyme Pharma, Inc. (INZY). Winton has reported 6 insider filings with the SEC since 2024. The most recent filing was in February 2026.
| Role | Chief Commercial and Business |
|---|---|
| Notability | 34/100 |
Board memberships
- CervoMed Inc.
- Inozyme Pharma, Inc.
Reported roles
- Chief Commercial and Business
Awards & honors
- Leadership in biotechnology
- Development of treatments for neurological disorders
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| Total purchases tracked | 3 |
|---|
Trading Pattern
InsiderAlpha's records for Matthew Winton go back to 2024: 6 primary Form 4 filings, an average of 2.0 per year. The typical open-market purchase is $39K (3 buys totaling $117K). The largest single buy on record is $76K of CRVO in 2025. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Career & Filing History
Every role Matthew Winton has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Chief Commercial and Business at CervoMed Inc. (CRVO) - 4 filings, 2025 to 2026
- COO at Inozyme Pharma, Inc. (INZY) - 2 filings, 2024 to 2025
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-11-19 | CRVO | CervoMed Inc. | P - Open-market purchase | 1.5K | $7.95 | $12K |
| 2025-11-19 | CRVO | CervoMed Inc. | P - Open-market purchase | 3.5K | $8.43 | $30K |
| 2025-11-17 | CRVO | CervoMed Inc. | P - Open-market purchase | 10.0K | $7.57 | $76K |
| 2025-07-01 | INZY | Inozyme Pharma, Inc. | J - Other acquisition / disposition | 21.7K | $4.00 | $87K |
| 2024-10-03 | INZY | Inozyme Pharma, Inc. | A - Grant or award | 1.7K | $4.45 | $8K |
Most Active Insiders Right Now
Matthew Winton has no recent co-filers at the same companies, so here are the insiders with the largest open-market activity across the market in the last 90 days.
- MetLife Investment Management, LLC - $1600000.00B of FINS open-market activity in the last 90 days
- Magnetar Financial LLC - $16357.48B of CRWV open-market activity in the last 90 days
- Marianne Okland - $18.46B of STNG open-market activity in the last 90 days
- VisionWave Holdings, Inc. - $14.13B of SVRE open-market activity in the last 90 days
- Vanessa Allen Sutherland - $7.44B of PSX open-market activity in the last 90 days
- AI Alpine (Luxembourg) S.a.r.l. - $2.69B of INIO open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Neil Mehta
- Keith A. Meister
- MetLife Investment Management, LLC
- John Micek
- Andrew J. Mills
- Charles N. Mills
- Kevin J. Mills
- Mink Brook Asset Management LLC
Frequently Asked Questions
Who is Matthew Winton?
Matthew Winton is the Chief Commercial and Business at CervoMed Inc. (CRVO). SEC records also connect Winton to Inozyme Pharma, Inc. (INZY). Winton has reported 6 insider filings with the SEC since 2024. The most recent filing was in February 2026.…
Has Matthew Winton been buying or selling stock?
Recorded transactions: 3 open-market purchases ($117K) and 0 open-market sales across all tracked filings.
How accurate is Matthew Winton's historical track record?
Across 3 tracked purchases, Matthew Winton averaged no 30-day data yet with a win rate pending. InsiderAlpha rates the track record at –/5 stars.
Where can I see all of Matthew Winton's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Matthew Winton profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.